ARGX:NASDAQ
argenx SE - ADR
US$ ९२२.७३
arrow_downward
-०.८४%(-७.७९) 1D
अक्टोबर ७, १५:२७:५८ GMT-४ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARGX...
Open
US$ ९३२.०८
High
US$ ९४२.६८
Low
US$ ९२२.२६
Mkt. cap
५८.४१ अरब
Avg. vol.
२.६० लाख
Volume
१.८० लाख
P/E ratio
३५.०६
52-wk high
US$ १,०७२.७५
52-wk low
US$ ६६१.८५
EPS
US$ २६.३२
Beta
०.४५
Shares outstanding
६.२९ करोड
No. of employees
२ हजार
Open
US$ ९३२.०८
High
US$ ९४२.६८
Low
US$ ९२२.२६
Mkt. cap
५८.४१ अरब
Avg. vol.
२.६० लाख
Volume
१.८० लाख
P/E ratio
३५.०६
52-wk high
US$ १,०७२.७५
52-wk low
US$ ६६१.८५
EPS
US$ २६.३२
Beta
०.४५
Shares outstanding
६.२९ करोड
No. of employees
२ हजार
News stories
From web sources and news partners
AD HOC NEWS
·
३ घण्टा पहिले
Argenx stock after-hours: EUR 839.00, prior close EUR 828.90
Zacks
·
४ घण्टा पहिले
HALO Expands ENHANZE Collaboration & Licensing Deal With ARGX
TradingView
·
५ घण्टा पहिले
HALO Expands ENHANZE Collaboration & Licensing Deal With ARGX
AD HOC NEWS
·
७ घण्टा पहिले
Argenx stock gained 1.93 percent as pipeline access expands
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About argenx SE - ADR